From: Adjuvant radiation therapy in metastatic lymph nodes from melanoma
Characteristic | Surgery | Surgery + radiotherapy | |
---|---|---|---|
No of patients | 26 (group 1) | 60 | |
Dose <50 Gy = 30 (group 2) | Dose >50 Gy = 30 (group 3) | ||
Age (y)* | 55 (27-87) | 52 (18-87) | |
Sex (F/M) | 9/16 | 20/41 | |
Interval ME-NM (y)* | 1(0-14) | 1(0-12) | |
Metastatic LN site (No of patients) | |||
Cervical | 4 | 17 | |
Axillary | 4 | 22 | |
Inguinal | 18 | 21 | |
Primary tumor | |||
Unknown | 0 | 1 | |
Breslow Index* | 2.475 (0.38-33) | 2.5 (0.15-33) | |
Clark Level* | 4 (4-3) | 4 (1-5) | |
Ulceration | 3 | 9 | |
Lymph node dissection | |||
Number of resected LN* | 11 (1-35) | 11 (1-36) | |
Number of positive LN* | 1 (1-9) | 2 (2-28) | |
ECE* | 1(0-3) | 1 (0-11) | |
Number of patients with LN size >3 cm | 13 | 23 |